{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:17:09Z","timestamp":1778753829164,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012619","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fragilidad y Envejecimiento Saludable","doi-asserted-by":"publisher","award":["PI19\/00033"],"award-info":[{"award-number":["PI19\/00033"]}],"id":[{"id":"10.13039\/100012619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012619","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fragilidad y Envejecimiento Saludable","doi-asserted-by":"publisher","award":["FIS PI16\/00818"],"award-info":[{"award-number":["FIS PI16\/00818"]}],"id":[{"id":"10.13039\/100012619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00043"],"award-info":[{"award-number":["2021 SGR 00043"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.maturitas.2025.108708","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T09:41:34Z","timestamp":1756546894000},"page":"108708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Changes in femoral 3D-DXA cortical and trabecular indices in postmenopausal women with early breast cancer treated with aromatase inhibitors: a prospective study of the B-ABLE cohort"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-0147","authenticated-orcid":false,"given":"Natalia","family":"Garcia-Giralt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Ovejero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Servitja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Martos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Soldado-Folgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Nogu\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.maturitas.2025.108708_bb0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update","volume":"37","author":"Burstein","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.maturitas.2025.108708_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/ERC-16-0025","article-title":"AI-related BMD variation in actual practice conditions: a prospective cohort study","volume":"23","author":"Rodriguez-Sanz","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.maturitas.2025.108708_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-384","article-title":"Increased fracture rate in women with breast cancer: a review of the hidden risk","volume":"11","author":"Body","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.maturitas.2025.108708_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx141","article-title":"Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast Cancer: a systematic review and Meta-analysis","volume":"110","author":"Goldvaser","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.maturitas.2025.108708_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jbmr.3886","article-title":"Increased fracture risk in women treated with aromatase inhibitors versus tamoxifen: beneficial effect of bisphosphonates","volume":"35","author":"Pineda-Moncusi","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.maturitas.2025.108708_bb0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/tbj.12783","article-title":"Extended adjuvant endocrine therapy in breast Cancer: evidence and update - a review","volume":"23","author":"Jinih","year":"2017","journal-title":"Breast J."},{"key":"10.1016\/j.maturitas.2025.108708_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2016.08.008","article-title":"TBS and BMD at the end of AI-therapy: a prospective study of the B-ABLE cohort","volume":"92","author":"Maria","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2025.108708_bb0040","first-page":"iv3","article-title":"Microarchitecture, the key to bone quality","volume":"48 Suppl 4","author":"Brandi","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.maturitas.2025.108708_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(18)30308-5","article-title":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the bone microarchitecture international consortium (BoMIC): a prospective study","volume":"7","author":"Samelson","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.maturitas.2025.108708_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmbbm.2016.06.004","article-title":"Experimental validation of DXA-based finite element models for prediction of femoral strength","volume":"63","author":"Dall\u2019Ara","year":"2016","journal-title":"J. Mech. Behav. Biomed. Mater."},{"issue":"3","key":"10.1016\/j.maturitas.2025.108708_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00198-019-05195-0","article-title":"IOF Working Group on Hip Bone Strength as a Therapeutic Target, Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk","volume":"31","author":"Bouxsein","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.maturitas.2025.108708_bb0060","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00198-021-05999-z","article-title":"The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions","volume":"32","author":"van den Bergh","year":"2021","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2025.108708_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1109\/RBME.2018.2876450","article-title":"Review of 2-D\/3-D reconstruction using statistical shape and intensity models and X-ray image synthesis: toward a unified framework","volume":"12","author":"Reyneke","year":"2019","journal-title":"IEEE Rev. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.maturitas.2025.108708_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1109\/TMI.2016.2593346","article-title":"3D-DXA: assessing the femoral shape, the trabecular macrostructure and the cortex in 3D from DXA images","volume":"36","author":"Humbert","year":"2017","journal-title":"IEEE Trans. Med. Imaging"},{"issue":"9","key":"10.1016\/j.maturitas.2025.108708_bb0075","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2215\/CJN.0000000000000213","article-title":"Long-term effect of Denosumab on bone disease in patients with CKD","volume":"18","author":"Iseri","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.maturitas.2025.108708_bb0080","article-title":"Do patients with type 2 diabetes have impaired hip bone microstructure? A study using 3D modeling of hip dual-energy X-ray absorptiometry","volume":"13","author":"Ubago-Guisado","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2025.108708_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040657","article-title":"3D DXA hip differences in patients with acromegaly or adult growth hormone deficiency","volume":"10","author":"Gracia-Marco","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2025.108708_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10612","article-title":"Proximal femur responses to sequential therapy with Abaloparatide followed by alendronate in postmenopausal women with osteoporosis by 3D modeling of hip dual-energy X-ray absorptiometry (DXA)","volume":"6","author":"Winzenrieth","year":"2022","journal-title":"JBMR Plus"},{"issue":"4","key":"10.1016\/j.maturitas.2025.108708_bb0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jbmr\/zjae028","article-title":"3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate","volume":"39","author":"Lewiecki","year":"2024","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.maturitas.2025.108708_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101471","article-title":"3D-DXA based finite element modelling for femur strength prediction: evaluation against QCT","volume":"27","author":"Qasim","year":"2024","journal-title":"J. Clin. Densitom."},{"issue":"4","key":"10.1016\/j.maturitas.2025.108708_bb0105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JOP.2016.011239","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast Cancer: American Society of Clinical Oncology clinical practice guideline update on ovarian suppression summary","volume":"12","author":"Burstein","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.maturitas.2025.108708_bb0110","article-title":"Efficacy of Antiresorptive drugs on bone mineral density in post-menopausal women with early breast Cancer receiving adjuvant aromatase inhibitors: a systematic review of randomized controlled trials","volume":"11","author":"de Sire","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2025.108708_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4158\/EP.14.2.162","article-title":"Prevention of bone loss after withdrawal of tamoxifen","volume":"14","author":"Cohen","year":"2008","journal-title":"Endocr. Pract."},{"issue":"6","key":"10.1016\/j.maturitas.2025.108708_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00223-015-0046-x","article-title":"Negative impact of aromatase inhibitors on proximal femoral bone mass and geometry in postmenopausal women with breast Cancer","volume":"97","author":"Lee","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.maturitas.2025.108708_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100409","article-title":"Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: a three-dimensional cortical bone mapping study","volume":"32","author":"Hong","year":"2022","journal-title":"J. Bone Oncol."},{"issue":"6","key":"10.1016\/j.maturitas.2025.108708_bb0130","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00774-021-01239-w","article-title":"Adjuvant endocrine therapy effects on bone mineral density and microstructure in women with breast cancer","volume":"39","author":"Kuba","year":"2021","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2025.108708_bb0135","first-page":"505","article-title":"Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density","volume":"65","author":"Nunes","year":"2021","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2025.108708_bb0140","article-title":"Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: a single center cross-sectional study","volume":"18","author":"Pedersini","year":"2023","journal-title":"Bone Rep."},{"issue":"10","key":"10.1016\/j.maturitas.2025.108708_bb0145","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00198-018-4624-4","article-title":"Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling","volume":"29","author":"Winzenrieth","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.maturitas.2025.108708_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00198-020-05806-1","article-title":"Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling","volume":"32","author":"Winzenrieth","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"11","key":"10.1016\/j.maturitas.2025.108708_bb0155","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann. Oncol."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222500516X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222500516X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:31:03Z","timestamp":1778751063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851222500516X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"alternative-id":["S037851222500516X"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2025.108708","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in femoral 3D-DXA cortical and trabecular indices in postmenopausal women with early breast cancer treated with aromatase inhibitors: a prospective study of the B-ABLE cohort","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2025.108708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108708"}}